Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Elgene Lim

Showing results (51-60 of 130) with videos related to

Pageof 13
Sort By:
Asia-Pacific Journal of Clinical Oncology|October 6, 2018
Hormone receptor positive, HER2 negative metastatic breast cancer: Impact of CDK4/6 inhibitors on the current treatment paradigmFrances Boyle, Jane Beith, Katie Burslem, et al.
Cancer Cell|July 12, 2011
Targeting androgen receptor in estrogen receptor-negative breast cancerMin Ni, Yiwen Chen, Elgene Lim, et al.
Breast Cancer Research and Treatment|November 23, 2018
The impact of ethnicity on efficacy and toxicity of cyclin D kinase 4/6 inhibitors in advanced breast cancer: a meta-analysisKirsty Wai Chung Lee, Sally Lord, Richard S Finn, et al.
Cancers|May 19, 2019
Immunoprofiling of Breast Cancer Antigens Using Antibodies Derived from Local Lymph NodesAnna Rachel Young, Jessica Da Gama Duarte, Rhiannon Coulson, et al.
Ebiomedicine|February 13, 2018
Vinorelbine Potently Induces Placental Cell Death, Does Not Harm Fertility and is a Potential Treatment for Ectopic PregnancyRoxanne Hastie, Elgene Lim, Pavel Sluka, et al.
Cancer Communications (London, England)|April 27, 2023
Triple combination targeting PI3K, ER, and CDK4/6 inhibits growth of ER-positive breast cancer resistant to fulvestrant and CDK4/6 or PI3K inhibitorLeena Karimi, Carla L Alves, Mikkel G Terp, et al.
Breast Cancer Research : BCR|March 30, 2010
Transcriptome analyses of mouse and human mammary cell subpopulations reveal multiple conserved genes and pathwaysElgene Lim, Di Wu, Bhupinder Pal, et al.
Cancer Research Communications|June 12, 2026
Stromal cell subsets modulate T-cell infiltration in early breast cancerJulia Chen, Hanyun Zhang, Travis Ruan, et al.
Cancer Cell|September 14, 2013
The RasGAP gene, RASAL2, is a tumor and metastasis suppressorSara Koenig McLaughlin, Sarah Naomi Olsen, Benjamin Dake, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 22, 2019
Estrogen receptor signaling is reprogrammed during breast tumorigenesisDavid Chi, Hari Singhal, Lewyn Li, et al.
Pageof 13

Showing results (51-60 of 130) with videos related to

Sort By:
Pageof 13
Asia-Pacific Journal of Clinical Oncology|October 6, 2018
Hormone receptor positive, HER2 negative metastatic breast cancer: Impact of CDK4/6 inhibitors on the current treatment paradigmFrances Boyle, Jane Beith, Katie Burslem, et al.
Cancer Cell|July 12, 2011
Targeting androgen receptor in estrogen receptor-negative breast cancerMin Ni, Yiwen Chen, Elgene Lim, et al.
Breast Cancer Research and Treatment|November 23, 2018
The impact of ethnicity on efficacy and toxicity of cyclin D kinase 4/6 inhibitors in advanced breast cancer: a meta-analysisKirsty Wai Chung Lee, Sally Lord, Richard S Finn, et al.
Cancers|May 19, 2019
Immunoprofiling of Breast Cancer Antigens Using Antibodies Derived from Local Lymph NodesAnna Rachel Young, Jessica Da Gama Duarte, Rhiannon Coulson, et al.
Ebiomedicine|February 13, 2018
Vinorelbine Potently Induces Placental Cell Death, Does Not Harm Fertility and is a Potential Treatment for Ectopic PregnancyRoxanne Hastie, Elgene Lim, Pavel Sluka, et al.
Cancer Communications (London, England)|April 27, 2023
Triple combination targeting PI3K, ER, and CDK4/6 inhibits growth of ER-positive breast cancer resistant to fulvestrant and CDK4/6 or PI3K inhibitorLeena Karimi, Carla L Alves, Mikkel G Terp, et al.
Breast Cancer Research : BCR|March 30, 2010
Transcriptome analyses of mouse and human mammary cell subpopulations reveal multiple conserved genes and pathwaysElgene Lim, Di Wu, Bhupinder Pal, et al.
Cancer Research Communications|June 12, 2026
Stromal cell subsets modulate T-cell infiltration in early breast cancerJulia Chen, Hanyun Zhang, Travis Ruan, et al.
Cancer Cell|September 14, 2013
The RasGAP gene, RASAL2, is a tumor and metastasis suppressorSara Koenig McLaughlin, Sarah Naomi Olsen, Benjamin Dake, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 22, 2019
Estrogen receptor signaling is reprogrammed during breast tumorigenesisDavid Chi, Hari Singhal, Lewyn Li, et al.
Pageof 13